Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Clin Microbiol Infect ; 21(1): 35-42, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25636925

ABSTRACT

Streptococcus pneumoniae is an important cause of acute otitis media (AOM). The aim of this study was to evaluate trends in antibiotic resistance and circulating serotypes of pneumococci isolated from middle ear fluid of French children with AOM during the period 2001-2011, before and after the introduction of the PCV-7 (2003) and PCV-13 (2010) vaccines. Between 2001 and 2011 the French pneumococcal surveillance network analysed the antibiotic susceptibility of 6683 S. pneumoniae isolated from children with AOM, of which 1569 were serotyped. We observed a significant overall increase in antibiotic susceptibility. Respective resistance (I+R) rates in 2001 and 2011 were 76.9% and 57.3% for penicillin, 43.0% and 29.8% for amoxicillin, and 28.6% and 13.0% for cefotaxime. We also found a marked reduction in vaccine serotypes after PCV-7 implementation, from 63.0% in 2001 to 13.2% in 2011, while the incidence of the additional six serotypes included in PCV-13 increased during the same period, with a particularly high proportion of 19A isolates. The proportion of some non-PCV-13 serotypes also increased between 2001 and 2011, especially 15A and 23A. Before PCV-7 implementation, most (70.8%) penicillin non-susceptible pneumococci belonged to PCV-7 serotypes, whereas in 2011, 56.8% of penicillin non-susceptible pneumococci belonged to serotype 19A. Between 2001 and 2011, antibiotic resistance among pneumococci responsible for AOM in France fell markedly, and PCV-7 serotypes were replaced by non-PCV-7 serotypes, especially 19A. We are continuing to assess the impact of PCV-13, introduced in France in 2010, on pneumococcal serotype circulation and antibiotic resistance.


Subject(s)
Drug Resistance, Bacterial , Otitis Media/epidemiology , Otitis Media/microbiology , Pneumococcal Infections/epidemiology , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/drug effects , Anti-Bacterial Agents/pharmacology , France/epidemiology , Humans , Incidence , Microbial Sensitivity Tests , Otitis Media with Effusion/microbiology , Pneumococcal Vaccines , Serogroup
3.
Pathol Biol (Paris) ; 58(2): e7-e14, 2010 Apr.
Article in French | MEDLINE | ID: mdl-19875246

ABSTRACT

AIM OF THE STUDY: To estimate the percentage of empirical treatments adapted in the bloodstream infections of community and not community origin and to determine the main circumstances in which this initial treatment is not adapted. PATIENTS AND METHODS: Surveillance of bloodstream infections from the laboratories of microbiology of the eight hospitals of the Ile-de-France network, during year 2007. The study concerned the patients hospitalised in medicine, surgery, obstetrics, intensive care, following care and rehabilitation, day hospitalisation, hospitalisation at home, who presented one or several episodes of bloodstream infections. RESULTS: During year 2007, 2013 bloodstream infections were analysed. Only 63.9% of bloodstream infections had an adapted initial antibiotic treatment. Among this proportion of bloodstream infections, an adapted empirical treatment concerned mainly the community episodes, the urinary tract, the pulmonary tract, or maternal-foetal episodes and the maternity ward and pediatrics. The percentage of adapted treatments was superior in the bloodstream infections where were isolated an Enterobacteriaceae, Streptococcus pneumoniae or other streptococci. On the contrary, only a quarter of bloodstream infections due to an Enterobacteriaceae producing BLSE or to a MRSA had received an adapted empirical treatment. CONCLUSION: Only two-thirds of the patients developing a bloodstream infection received an adapted initial antibiotic treatment. This proportion was even lower when it was not about a community origin, in spite of the frequent administration of several anti-infectious molecules or with wide spectrum.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteremia/epidemiology , Community-Acquired Infections/epidemiology , Cross Infection/epidemiology , Drug Resistance, Multiple, Bacterial , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia/drug therapy , Bacteremia/microbiology , Child , Child, Preschool , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Cross Infection/drug therapy , Cross Infection/microbiology , Drug Utilization , Enterobacteriaceae/drug effects , Enterobacteriaceae/isolation & purification , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/epidemiology , Enterobacteriaceae Infections/microbiology , Female , France/epidemiology , Humans , Incidence , Infant , Inpatients/statistics & numerical data , Male , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Middle Aged , Outpatients/statistics & numerical data , Population Surveillance , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Streptococcal Infections/drug therapy , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Streptococcus/drug effects , Streptococcus/isolation & purification , Young Adult
4.
Pathol Biol (Paris) ; 52(8): 469-73, 2004 Oct.
Article in French | MEDLINE | ID: mdl-15465266

ABSTRACT

To estimate the incidence of nosocomial infections (NI) in our hospital and to increase healthcare professionals' awareness of hygiene, a prospective study was performed between January and December 2002 from the microbiology laboratory data. On 1334 suspicions of NI, corresponding to 1062 patients, sent to the hygiene correspondents in each medical care unit, the infection control team received 853 answers (64% of sendings) with 430 NI validated. The incidence rate of NI validated was 1.7 NI/1000 days of hospitalisation and 1.6 NI/100 inpatients. The NI were predominantly related to urinary tract (47%), bloodstream (14%), and lower respiratory tract (12%). Transmission of these informations to medical information department permitted a valorisation of additional 16,000 ISA points. This prospective study permitted to develop a network of hygiene correspondents in every medical care units. None of the medical care units was unharmed by NI but the exhaustive declaration of NI seems difficult to realise. This study permitted to point out some dysfunctionments in the management of invasive procedures and to improve these practices.


Subject(s)
Bacterial Infections/epidemiology , Cross Infection/epidemiology , Bacterial Infections/classification , Cross Infection/prevention & control , France/epidemiology , Hospitals, General/statistics & numerical data , Humans , Hygiene , Incidence , Inpatients , Reproducibility of Results
5.
Med Mal Infect ; 34(7): 303-9, 2004 Jul.
Article in French | MEDLINE | ID: mdl-15679234

ABSTRACT

OBJECTIVE: The authors wanted to assess the level of Streptococcus pneumoniae antibiotic resistance in Ile de France. METHOD: In 2001, 637 clinical strains of S. pneumoniae were prospectively collected from 32 microbiology laboratories. RESULTS: Fifty one percent of strains were isolated from children under 15 years of age and 49% from adults. In children, 76% of strains came from otitis media, 20% from blood culture, in adults most strains (92%) came from blood culture. The overall prevalence of non-susceptible penicillin pneumococci was 61% higher in children (73%) than in adults (50%). Among the non-susceptible penicillin pneumococci 21.8% were resistant (CMI > 1 mg/l). Strains with decreased susceptibility to amoxicillin and cefotaxime were 38% and 17% respectively. Resistant strains to these two drugs (CMI > 2 mg/l) were rare 2.6% and 0.4% respectively. Among other antimicrobial agents, rate of resistance was 63% to erythromycin, 47% to cotrimoxazole, 40% to tetracycline, and 23% to chloramphenicol. The most frequent serogroups were serogroups 19 and 14, respectively 23% and 18%. Serotypes included in heptavalent vaccine covered 90% of children strains under 2 years of age. CONCLUSIONS: The prevalence of resistance to penicillin was high in children particularly in otitis media pus (76%).


Subject(s)
Pneumococcal Infections/drug therapy , Pneumococcal Infections/epidemiology , Streptococcus pneumoniae/drug effects , Adult , Child , Drug Resistance, Bacterial , France/epidemiology , Humans , Prevalence , Prospective Studies , Streptococcus pneumoniae/isolation & purification
6.
Ann Biol Clin (Paris) ; 61(1): 49-59, 2003.
Article in French | MEDLINE | ID: mdl-12604386

ABSTRACT

Over the last years, the emergence of resistance to antibiotics has complicated the management of streptococcal infections. The resistance of streptococci to antibiotics is increasing and seems to be linked to the consumption of antibiotics. Resistances to antibiotics have been noted in all species of streptococci and no family of antibiotics is unaffected by resistances. The incidence of resistance to antibiotics varies from one species to another and according to countries. Presently, even though no Streptococcus pyogenes has shown diminished susceptibility to betalactams, this phenomenon has been reported for some strains in the B, C, and G groups, and for up to 56 % of oral streptococci. As for the resistance to macrolides, it reaches as many as 41 % of Streptococcus pyogenes, 46 % of group B streptococci, and 63 % of oral streptococci responsible for severe infections. This evolution is worrying for all streptococci but particularly for oral streptococci which represent a potential reservoir of virulence genes, notably towards Streptococcus pneumoniae. New families of antibiotics as the ketolides or the oxazolidinones appear to be effective in the treatment of streptococcal infections, but it seems that only a policy of control of the consumption of antibiotics could globally decrease the occurrence of resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Enterococcus/drug effects , Microbial Sensitivity Tests , Streptococcus/drug effects , Drug Resistance, Bacterial , Enterococcus/classification , Enterococcus/isolation & purification , Humans , Species Specificity , Streptococcus/classification , Streptococcus/isolation & purification , Tetracycline Resistance
8.
Rev Chir Orthop Reparatrice Appar Mot ; 88(6): 625-7, 2002 Oct.
Article in French | MEDLINE | ID: mdl-12447133

ABSTRACT

Bone infection is not an uncommon complication of open tibial shaft fractures. We report an unusual case of chronic tibial osteitis caused by Pantoea agglomerans after an open grade IIIB tibial shaft fracture. P. agglomerans, an enterobacteria, was identified on bone samples obtained nine months after the fracture. The infection probably resulted from the initial soil contamination and developed despite fixation and bone covering with a muscle flap performed during the same operative time and adapted intravenous antibiotics.


Subject(s)
Fractures, Open/complications , Gram-Negative Bacterial Infections/etiology , Osteitis/etiology , Pantoea , Tibial Fractures/complications , Accidents, Traffic , Anti-Bacterial Agents/therapeutic use , Chronic Disease , Combined Modality Therapy , Fracture Fixation, Internal , Fractures, Open/classification , Fractures, Open/diagnostic imaging , Fractures, Open/therapy , Gram-Negative Bacterial Infections/diagnosis , Humans , Injury Severity Score , Male , Middle Aged , Osteitis/diagnosis , Radiography , Soil Microbiology , Surgical Flaps , Tibial Fractures/classification , Tibial Fractures/diagnostic imaging , Tibial Fractures/therapy
10.
Pathol Biol (Paris) ; 43(4): 315-9, 1995 Apr.
Article in French | MEDLINE | ID: mdl-7567122

ABSTRACT

We analyzed the beta-lactamase production of a Serratia fonticola isolated for its resistance to cefuroxime (Minimum Inhibitory Concentration > 256 mg/l) in December 1993 from a patient hospitalized in Meaux. The wild strain was resistant to amoxycillin but sensitive to augmentin, that suggested the production of a beta-lactamase susceptible to clavulanic acid. For the wild strain, beta-lactamase production was inducible and only one enzyme with an isoelectric point of 8.12 was detected. beta-lactamase production was 16 mU/mg for non-induced extracts and ranged from 100 to 230 mU/mg in the presence of inducing beta-lactams (enzyme activity was measured with penicillin G as substrate). On a Szybalski gradient a constitutive strain was obtained. Its enzyme production was 13,000 mU/mg. The kinetics and isoelectric points of the enzymes produced by the two strains were identical. This beta-lactamase hydrolyzes penicillins (amoxycillin: Vm = 60 relative to penicillin G = 100, ticarcillin: 15), first generation cephalosporins (cephalothin Vm = 930). However, this enzyme hydrolyzes efficiently oxyimino-cephalosporins: cefuroxime (Vm = 70) and cefotaxime (Vm = 120), but cephamycins are not substrates. Clavulanic acid has a very good affinity for this beta-lactamase (Ki = 0.09 microM) which is inactivated progressively (I50 = 0.045 microgram/ml). These properties shows some similarities with those of the class A beta-lactamases of P. vulgaris RO104 (pI = 8.3), P. penneri 14HBC (pI = 6.65) and the plasmid-mediated extended-spectrum MEN-1 (pI = 8.4).


Subject(s)
Anti-Bacterial Agents/pharmacology , Cephalosporinase/isolation & purification , Clavulanic Acids/pharmacology , Serratia/enzymology , Aged , Cephalosporinase/chemistry , Cephalosporinase/pharmacokinetics , Clavulanic Acid , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Female , Humans , In Vitro Techniques , Isoelectric Focusing , Serratia/drug effects , Serratia/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...